Wannhoff, A., Brune, M., Knierim, J., Weiss, K. H., Rupp, C., & Gotthardt, D. (2019). Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis. Alimentary pharmacology & therapeutics, 49(6), . https://doi.org/10.1111/apt.15146
Chicago-Zitierstil (17. Ausg.)Wannhoff, Andreas, Maik Brune, Johannes Knierim, Karl Heinz Weiss, Christian Rupp, und Daniel Gotthardt. "Longitudinal Analysis of CA19-9 Reveals Individualised Normal Range and Early Changes Before Development of Biliary Tract Cancer in Patients with Primary Sclerosing Cholangitis." Alimentary Pharmacology & Therapeutics 49, no. 6 (2019). https://doi.org/10.1111/apt.15146.
MLA-Zitierstil (9. Ausg.)Wannhoff, Andreas, et al. "Longitudinal Analysis of CA19-9 Reveals Individualised Normal Range and Early Changes Before Development of Biliary Tract Cancer in Patients with Primary Sclerosing Cholangitis." Alimentary Pharmacology & Therapeutics, vol. 49, no. 6, 2019, https://doi.org/10.1111/apt.15146.